InsidersTradesSigma
Track the PHARMANUTRA FIRST HALF 2023 RESULTS stock price and the full directors' dealings record of the company, a listed equity based in Italy. Shares trade on the IT market, under the supervision of Consob. Operating in the Health Care sector, PHARMANUTRA FIRST HALF 2023 RESULTS has logged 0 insider filings. The full history is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
No declarations found
0 of 0 declarations
PHARMANUTRA released its first half 2023 results, demonstrating strong performance in the health and pharmaceutical sector. The company is listed on the XMIL market.